IMMUNEONCO BIOPHARMA

immuneonco-biopharma-logo

ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells.

#SimilarOrganizations #People #Financial #Website #More

IMMUNEONCO BIOPHARMA

Industry:
Biopharma Biotechnology Health Care

Founded:
2015-06-01

Address:
Shanghai, Shanghai, China

Country:
China

Website Url:
http://www.immuneonco.com

Total Employee:
11+

Status:
Active

Contact:
+86-21-58356573

Email Addresses:
[email protected]

Total Funding:
147.21 M USD

Technology used in webpage:
SPF China Telecom Alibaba Cloud MailBox


Similar Organizations

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

innovative-cellular-therapeutics-logo

Innovative Cellular Therapeutics

Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.

Current Employees Featured

wenzhi-tian_image

Wenzhi Tian
Wenzhi Tian Chairman, Founder, and CEO @ ImmuneOnco Biopharma
Chairman, Founder, and CEO
2015-01-01

Founder


wenzhi-tian_image

Wenzhi Tian

Investors List

shanghai-milestone-asset-management_image

Milestone

Milestone investment in Series C - ImmuneOnco Biopharma

sunshine-insurance-group-co-ltd_image

Sunshine Insurance Group

Sunshine Insurance Group investment in Series C - ImmuneOnco Biopharma

ccb-trust-co_image

CCB Trust

CCB Trust investment in Series C - ImmuneOnco Biopharma

lilly-asia-ventures_image

Lilly Asia Ventures

Lilly Asia Ventures investment in Series C - ImmuneOnco Biopharma

founder-h-fund_image

Founder H Fund

Founder H Fund investment in Series C - ImmuneOnco Biopharma

cdf-capital_image

CDF-Capital

CDF-Capital investment in Series C - ImmuneOnco Biopharma

cash-capital_image

CASH Capital

CASH Capital investment in Series C - ImmuneOnco Biopharma

zhangke-lingyi-investment_image

Zhangke Lingyi Investment

Zhangke Lingyi Investment investment in Series C - ImmuneOnco Biopharma

shanghai-international-group-sig_image

Shanghai International Group (SIG)

Shanghai International Group (SIG) investment in Series C - ImmuneOnco Biopharma

lyfe-capital-2_image

LYFE Capital

LYFE Capital investment in Series C - ImmuneOnco Biopharma

Official Site Inspections

http://www.immuneonco.com Semrush global rank: 7.79 M Semrush visits lastest month: 437

  • Host name: 121.199.6.220
  • IP address: 121.199.6.220
  • Location: Hangzhou China
  • Latitude: 30.294
  • Longitude: 120.1619
  • Timezone: Asia/Shanghai

Loading ...

More informations about "ImmuneOnco Biopharma" on Search Engine